Table 6.
Verification of the research hypotheses on the moderating effect.
| Hypothesis (path) and group | β | Estimate | SE | P-value | Critical ratio for differences | |||||||
| H9 (PEa→BIb) | –0.934 | |||||||||||
|
|
CDc | .438 | 0.516 | 0.188 | .006 |
|
||||||
|
|
No CD | .429 | 0.508 | 0.393 | .429 |
|
||||||
| H10 (DTd→BI) | 0.780 | |||||||||||
|
|
CD | .060 | 0.069 | 0.146 | .060 |
|
||||||
|
|
No CD | .215 | 0.277 | 0.224 | .215 |
|
||||||
| H11 (DT→PE) | –2.165 | |||||||||||
|
|
CD | .278 | 0.272 | 0.083 | .001 |
|
||||||
|
|
No CD | –.100 | –0.107 | 0.154 | .487 |
|
||||||
aPE: performance expectancy.
bBI: behavioral intention.
cCD: chronic disease.
dDT: device trust.